Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frytak

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancerW C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials|January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancerR T Eagan, S Frytak, R E Lee, et al.
Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Mayo Clinic Proceedings|February 1, 1989
Cytogenetic studies in 11 patients with small cell carcinoma of the lungP A De Fusco, S Frytak, R J Dahl, et al.
Cancer Research|August 1, 1982
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposureJ N Ingle, S J Green, D L Ahmann, et al.
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasJ H Edmonson, L M Ryan, R H Blum, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancerW C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials|January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancerR T Eagan, S Frytak, R E Lee, et al.
Investigational New Drugs|August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephromaH J Long, M D Hauge, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Mayo Clinic Proceedings|February 1, 1989
Cytogenetic studies in 11 patients with small cell carcinoma of the lungP A De Fusco, S Frytak, R J Dahl, et al.
Cancer Research|August 1, 1982
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposureJ N Ingle, S J Green, D L Ahmann, et al.
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasJ H Edmonson, L M Ryan, R H Blum, et al.
Pageof 11